MERCK KGAA |
Market Closed -
Other stock markets
|
After market 02:09:48 pm | |||
| 171.3 EUR | -0.35% |
|
171.2 | -0.03% |
| Jun. 06 | Merck KGaA Completes EUR180 Million German Distribution Center Expansion | MT |
| Jun. 06 | Merck Opens Newly Expanded Life Science Distribution Center in Schnelldorf, Germany | CI |
ETFs positioned on Merck KGaA
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.34% | 2 M€ | +13.56% | - | |
| 1.80% | 962 M€ | -.--% | - | |
| 1.20% | 79 M€ | -.--% | ||
| 0.97% | 21 M€ | +8.41% | - | |
| 0.77% | 17 M€ | 0.00% | ||
| 0.75% | 18 M€ | +7.68% | ||
| 0.58% | 2 M€ | +11.23% | ||
| 0.47% | 251 M€ | +10.53% | ||
| 0.43% | 88 M€ | +10.37% | - | |
| 0.35% | 6 M€ | -.--% | - | |
| 0.33% | 252 M€ | +7.82% | ||
| 0.30% | 4 M€ | -.--% | - | |
| 0.29% | 6 M€ | -.--% | ||
| 0.23% | 469 M€ | -2.05% | ||
| 0.23% | 3,859 M€ | +18.82% | - | |
| 0.13% | 10 M€ | -3.35% | - | |
| 0.11% | 276 M€ | +11.40% | - | |
| 0.11% | 31 M€ | +0.28% | - | |
| 0.09% | 261 M€ | -.--% | - | |
| 0.09% | 200 M€ | +11.96% | - | |
| 0.09% | 488 M€ | +14.56% | ||
| 0.09% | 35 M€ | +6.41% | - | |
| 0.06% | 205 M€ | -.--% |
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:
- solutions and products for scientific and biotechnological research (44.2%);
- pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.
Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
Pharmaceuticals
Calendar
2024-07-31
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
171.9
EUR
Average target price
186.1
EUR
Spread / Average Target
+8.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.88% | 81.33B | |
| +14.11% | 9.14B | |
| -14.14% | 4.89B | |
| +43.39% | 4.61B | |
| +18.90% | 4.36B | |
| +7.93% | 2.26B | |
| -28.40% | 2.15B | |
| +15.93% | 2.1B | |
| -43.17% | 1.78B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock
- Funds and ETFs Merck KGaA
